AXR vs CLOV · P/E 11, rev $49.7M vs rev $1.37B
AMREP Corporation (AXR) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
AMREP Corporation (AXR) is a real estate - development company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AXR revenue for 2025-04-30 was $49.7M. Net income was $12.7M. AXR currently screens at market cap $135.4M and trailing P/E 10.6.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AXR currently screens at market cap $135.4M and trailing P/E 10.6. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AXR and CLOV stock pages for the full models.
Not investment advice.